Defending against the rising threat of drug-resistant fungal sepsis

Understanding the complexity of fungal sepsis caused by Candida species may seem daunting. Which methods are effective in fighting elusive strains? Which tools are best at identifying them? What can those results do to help clinicians make better decisions? These are complex questions, but one thing is certain: Appropriate laboratory diagnostics like antimicrobial susceptibility testing (AST) and emerging research can help turn the tide in the fight against fungal sepsis.

Discover how Thermo Fisher Scientific gives laboratories and physicians the data they need to make critical decisions in cases of resistant fungal sepsis. Explore how your clinical laboratory can be part of the solution with advanced tools and resources.